Product Information
FLUVOXAMINE ER 150 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $4.6085 per EA under NDC 27241027530. Its NADAC has been published 80 times since Feb 12, 2025.
FDA first approved this application on Oct 17, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241027530
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA219055FDA Approved
10/17/2024
TE Code
AB
On Market Since
10/17/2024
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE ER 150 MG CAPSULE has been published 80 times since Feb 12, 2025, and over the history we have for it it has declined 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6085 per EA |
|---|---|
| All-time high | $5.6209 (Aug 13, 2025) |
| All-time low | $4.6085 (Aug 19, 2026) |
| 52-week high | $5.6059 |
| 52-week low | $4.6085 |
| Median price | $5.2792 |
| Average price | $5.2066 |
| Largest weekly change | +9.3% (Feb 19, 2025) |
| Weeks tracked | 80 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUVOXAMINE ER 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE ER 150 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $4.6085 per EA (NDC 27241027530), effective Aug 19, 2026.
How has the price of FLUVOXAMINE ER 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has declined 6.5%. It has been tracked across 80 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE ER 150 MG CAPSULE?
Since Feb 12, 2025, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has ranged from a low of $4.6085 (Aug 19, 2026) to a high of $5.6209 (Aug 13, 2025), with a median of $5.2792 per EA.
Are there cheaper alternatives to FLUVOXAMINE ER 150 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUVOXAMINE ER 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUVOXAMINE ER 150 MG CAPSULE?
FLUVOXAMINE ER 150 MG CAPSULE (NDC 27241027530) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.